If you need more lookups,
subscriptions start at $34 USD/month.
Ming Lei Location
United States
Ming Lei Work
2015 -now CEO @
2013 -2015 Sr. Principal Biomedical Engineer @ Haemonetics, THE Blood Management Company
2002 -2012 Staff Scientist and Group Leader @ 454 Life Sciences/Roche Diagnostics
2001 -2002 Sr. Microfluidic Engineer and Group Leader @ BioMicro Systems (acquired by Roche NimbleGen)
2001 -2002 Sr. Microfluidic Engineer and Group Leader @ BioMicro Systems
1997 -2001 Sr. Engineer @
Ming Lei Education
The Johns Hopkins University School of Medicine
(Biomedical Engineering)
1996-1997
North Carolina State University
Doctor of Philosophy (Biomedical Engineering)
1991-1996
Industrial Design Tu/E
(Engineering)
1990-1991
Sichuan University
Bachelor of Science
Ming Lei Skills
Biotechnology
Lifesciences
Microfluidics
DNA sequencing
Sequencing
Genomics
Molecular Biology
R&D
PCR
Biomedical Engineering
Medical Devices
Experimentation
Laboratory
Assay Development
DNA
Ming Lei Summary
Ming Lei, based in United States, is currently a CEO at Universal Sequencing Technology. Ming Lei brings experience from previous roles at Haemonetics, THE Blood Management Company, 454 Life Sciences/Roche Diagnostics, BioMicro Systems (acquired by Roche NimbleGen) and BioMicro Systems. Ming Lei holds a 1996 - 1997 The Johns Hopkins University School of Medicine. With a robust skill set that includes Biotechnology, Lifesciences, Microfluidics, DNA sequencing, Sequencing and more. Ming Lei has 2 emails and 3 mobile phone numbers on RocketReach.
Looking for a different Ming Lei?
Find contact details for 700 million professionals.